On the contrary, miR-541 sensitized HCC cells to sorafenib treatment by inhibiting the expression of two autophagy-related genes, ATG2A (autophagy-related 2A) and RAB1B, highlighting the opposite role attributed to autophagy on drug sensitization [84]. The gene discussed is ATG2A; the disease is hepatocellular carcinoma.